NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms

) Generic Name asprin (ASA) Classification Dose Route Time/frequency Antipyretics, 325 mg PO Q am salicylates, nonopiod analgesics Peak Onset Duration Normal dosage range 1-3 hr 5-30 min 3-6 hr 1-1.3 g daily in 2-4 divided doses (doses as low as 325 mg/day may be used in patients who are intolerant of the higher dose) Why is your patient getting this medication For IV meds, compatibility with IV drips and/or Prophylaxis of TIA, MI solutions N/A Mechanism of action and indications Nursing Implications (what to focus on) (Why med ordered) Contraindications/warnings/interactions Decreases platelet aggregation. Hypersensitivity to aspirin, tartrazine (FDC yellow dye #5), or other salicylates. Cross-sensitivity with other NSAIDs may exist (less with nonaspirin salicylates). Bleeding disorders or thrombocytopenia (more important with aspirin). Common side effects Dyspepsia, epigastric distress, heartburn, nausea. Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this patient Lab value alterations caused by medicine May cause ↑ serum AST, ALT, and alkaline phosphatase, especially when plasma concentrations exceed 25 mg/100 ml. May alter results of serum uric acid, urine vanillylmandelic acid (VMA), protirelin-induced thyroidstimulating hormone (TSH), urine hydroxyindoleacetic acid (5-HIAA) determinations, and radionuclide thyroid imaging. May cause ↓ serum potassium and cholesterol concentrations. Be sure to teach the patient the following about this medication Advise patients receiving aspirin prophylactically to take only prescribed dose. Increasing the dose has not been found to provide additional benefits. Instruct patient to take salicylates with a full glass of water and to remain in an upright position for 15-30 min after administration. Trade Name Ecotrin

Nursing Process- Assessment (Pre-administration assessment) Ensure patient has no history of asthma, allergies, nasal polyps or tartrazine allergies (Patients who have asthma, allergies, and nasal polyps or who are allergic to tartrazine are at an increased risk for developing hypersensitivity reactions).

Assessment Why would you hold or not give this med? Monitor patient for the onset of tinnitus, headache, hyperventilation, agitation, mental confusion, lethargy, diarrhea, and sweating. If these symptoms appear, withhold medication and notify physician or other health care professional immediately.

Evaluation Check after giving Prevention of TIA, MI

Sign up to vote on this title
UsefulNot useful